DrugDashboards

Capecitabine

Capecitabine · CAPECITABINE 500 mg/1 · Tablet, Film Coated · Oral · American Health Packaging

NDC 60687-0149-94 · 20 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, FILM COATED in 1 BLISTER PACK · ANDA · View full market →

The short version

17 companies supply this market — deep enough that no single failure threatens the supply. The price is down 8% over the past year, to $0.4679 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.4679per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.0800per billing unit (50 MG)HCPCS J8522 · Jul 1, 2026
  • Part D plans paid (avg)$2.99per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.5571per TABweighted avg manufacturer price $0.3183 · Aug 1, 2026119% of what pharmacies pay — higher than 67% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00$30.00Apr 2016Sep 2026$0.4679
70 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$14.04
#90 count
$42.11

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicare Part B (ASP)

Payment limit per 50 MG
$0.080
HCPCS J8522 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for capecitabine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA091649
TE code
AB
Approval date
Sep 16, 2013
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Capecitabine (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
BluePoint LaboratoriesCAPECITABINE 500 mg/1Jul 15, 2026Sep 3, 2026
BluePoint LaboratoriesCAPECITABINE 150 mg/1Jul 15, 2026Sep 3, 2026
Accord Healthcare Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Excella GmbH & Co. KGCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Capecitabine — NDC 60687-0149-94," retrieved September 3, 2026, https://drugdashboards.com/drug/60687014994.

Free to cite with attribution — see how the data is put together.